dc.contributor.author |
Opoka, Robert O. |
|
dc.contributor.author |
Hamre, Karen E. S. |
|
dc.contributor.author |
Brand, Nathan |
|
dc.contributor.author |
Bangirana, Paul |
|
dc.contributor.author |
Idro, Richard |
|
dc.contributor.author |
John, Chandy C. |
|
dc.date.accessioned |
2021-01-01T21:57:58Z |
|
dc.date.available |
2021-01-01T21:57:58Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
2048-7193 |
|
dc.identifier.uri |
http://combine.alvar.ug/handle/1/48093 |
|
dc.description.abstract |
Background. Cerebral malaria (CM) and severe malarial anemia (SMA) account for a substantial proportion of malaria-related deaths in sub-Saharan Africa. However, postdischarge morbidity in children with CM or SMA has not been well established. Methods. Children 18 months to 12 years of age, enrolled on admission to Mulago National Referral Hospital in Kampala, Uganda (CM, n = 162; SMA, n = 138), and healthy children recruited from the community (CC) (n = 133) were followed up for 6 months. The incidences of hospitalizations and outpatient clinic visits for illness during the follow-up period were compared between children with CM or SMA and the CC. Results. After adjustment for age, sex, and nutritional status, children with SMA had a higher incidence rate ratio (IRR) than CC for hospitalization (95% confidence interval [CI], 20.81 [2.48-174.68]), hospitalization with malaria (17.29 [95% CI, 2.02-148.35]), and clinic visits for any illness (95% CI, 2.35 [1.22-4.51]). Adjusted IRRs for children with CM were also increased for all measures compared with those for CC, but they achieved statistical significance only for clinic visits for any illness (2.24 [95% CI, 1.20-4.15]). In both groups, the primary reason for the clinic visits and hospitalizations was malaria. Conclusions. In the 6 months after initial hospitalization, children with SMA have an increased risk of repeated hospitalization, and children with CM or SMA have an increased risk of outpatient illness. Malaria is the main cause of inpatient and outpatient morbidity. Malaria prophylaxis has the potential to decrease postdischarge morbidity rates in children with SMA or CM.] |
|
dc.description.sponsorship |
National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) |
|
dc.description.sponsorship |
Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R01NS055349, D43 NS078280] |
|
dc.description.sponsorship |
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349] Funding Source: NIH RePORTER |
|
dc.language |
English |
|
dc.publisher |
OXFORD UNIV PRESS |
|
dc.relation.ispartof |
Journal of the Pediatric Infectious Diseases Society |
|
dc.subject |
Cerebral Malaria |
|
dc.subject |
Incidence |
|
dc.subject |
Readmission |
|
dc.subject |
Severe Malarial Anemia |
|
dc.title |
High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria |
|
dc.type |
Article |
|
dc.identifier.isi |
000416622700006 |
|
dc.identifier.doi |
10.1093/jpids/piw060 |
|
dc.identifier.pmid |
28339598 |
|
dc.publisher.city |
OXFORD |
|
dc.publisher.address |
GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND |
|
dc.identifier.eissn |
2048-7207 |
|
dc.identifier.volume |
6 |
|
dc.identifier.issue |
3 |
|
dc.identifier.spage |
E41 |
|
dc.identifier.epage |
E48 |
|
dc.subject.wc |
Infectious Diseases |
|
dc.subject.wc |
Pediatrics |
|
dc.subject.sc |
Infectious Diseases |
|
dc.subject.sc |
Pediatrics |
|
dc.description.oa |
Green Published |
|
dc.description.pages |
8 |
|
dc.subject.kwp |
Plasmodium-Falciparum Malaria |
|
dc.subject.kwp |
Placebo-Controlled Trial |
|
dc.subject.kwp |
Western Kenya |
|
dc.subject.kwp |
Mortality |
|
dc.subject.kwp |
Transfusion |
|
dc.subject.kwp |
Multicenter |
|
dc.subject.kwp |
Impairment |
|
dc.subject.kwp |
Sequelae |
|
dc.description.affiliation |
Makerere Univ, Dept Paediat, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Dept Psychiat, Kampala, Uganda |
|
dc.description.affiliation |
Univ Minnesota, Div Global Pediat, Minneapolis, MN USA |
|
dc.description.affiliation |
Columbia Coll Phys & Surg, New York, NY USA |
|
dc.description.affiliation |
Indiana Univ, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA |
|
dc.description.email |
chjohn@iu.edu |
|
dc.description.corr |
John, CC (corresponding author), Ryan White Ctr Pediat Infect Dis & Global Hlth, 1044 W Walnut St,R4 402D, Indianapolis, IN 44202 USA. |
|
dc.description.orcid |
Idro, Richard/0000-0003-4728-4605 |
|